Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 4—April 2013
CME ACTIVITY - Research

Serotype IV and Invasive Group B Streptococcus Disease in Neonates, Minnesota, USA, 2000–20101

Patricia FerrieriComments to Author , Ruth Lynfield, Roberta Creti, and Aurea E. Flores
Author affiliations: University of Minnesota Medical School, Minneapolis, Minnesota, USA (P. Ferrieri, A.E. Flores); Minnesota Department of Health, St. Paul, Minnesota, USA (R. Lynfield); Istituto Superiore di Sanità, Rome, Italy (R. Creti)

Main Article

Table 1

Distribution of GBS invasive disease in infants by isolate source and age of infant at time of culture, Minnesota, USA, 2000–2010*

Culture source No. infants with GBS invasive disease†
 Total
Early onset Late onset
7–89 90–180 >181
Blood 251 142 10 3 406
Cerebrospinal fluid 4 37 1 1 43
Other sites‡
 2
 1
 1
 0
 4
All 257 180 12 4 453

*GBS, group B Streptococcus.
†No. isolates studied were 1 per infant (n = 453). Early-onset is birth–6 days. Late-onset categories (age in days at time of culture): classical (7–89); delayed (90–180); ultra (>181; not included in analyses).
‡Other sites, normally sterile: 1 bone, 1 joint, 2 tissues (1 liver, 1 lung).

Main Article

1This work was presented in part at the XVIII Lancefield International Symposium on Streptococci and Streptococcal Diseases, September 4–8, 2011, Palermo, Italy.

Page created: March 14, 2013
Page updated: March 14, 2013
Page reviewed: March 14, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external